Antibody Developability Prediction - Creative Biolabs

Developability, which can be used as an additional selection factor, is the likelihood that a lead candidate would be successfully developed into a stable, safe, producible, and effective medication. A series of quick, accurate, and predictive assays that target biochemical and biophysical characteristics, along with in silico analysis, make it possible to assess a clinical candidate molecule with promising qualities early in the drug development process. Years of research into antibody engineering have allowed us to develop a comprehensive in silico technological platform. We provide top-notch antibody developability prediction services, such as antibody aggregation and immunogenicity prediction, to clients worldwide on the basis of our cutting-edge platform.